on 13 Dec 2022
Last Applicant/ Owned by
140 First Street, Suite 501
CAMBRIDGE
MA
02141
Serial Number
90708918 filed on 13th May 2021
Registration Number
6926111 registered on 13th Dec 2022
Correspondent Address
Christina M. Licursi, Esq.
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Pharmaceutical agents affecting DNA structure by targeting DNA structure to treat various diseases in the nature of monogenic diseases, cancer, infectious disease, immune disease, hematological conditions, haploinsufficiencies, hepatic disease, channelopathies, endocrine disease, cardiovascular disease, reproductive disease, renal disease, skeletal muscle disease, bone disease, none of the foregoi Read More
Pharmaceutical agents affecting DNA structure by targeting DNA structure to treat various diseases in the nature of monogenic diseases, cancer, infectious disease, immune disease, hematological conditions, haploinsufficiencies, hepatic disease, channelopathies, endocrine disease, cardiovascular disease, reproductive disease, renal disease, skeletal muscle disease, bone disease, none of the foregoing including omega fatty acids
31st Jul 2022
31st Jul 2022
No 90708918
No Service/Collective Mark
No V02982001200
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
01st Jun 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
01st Jun 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
01st Jun 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
01st Jun 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
01st Jun 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
13th Dec 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
13th Dec 2022 | REGISTERED-PRINCIPAL REGISTER |
05th Nov 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
04th Nov 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
06th Oct 2022 | STATEMENT OF USE PROCESSING COMPLETE |